Isomorphic Labs Secures $2.1B Series B to Accelerate AI Drug Discovery
Isomorphic Labs raised $2.1 billion to scale its IsoDDE AI drug design engine. Backed by Thrive Capital, Alphabet, Temasek and the UK’s sovereign AI fund, the funding aims to speed therapeutic programs toward clinic.
Isomorphic Labs Secures $2.1B Series B to Accelerate AI Drug Discovery Read More »










